InsidersTradesSigma
Track the 奥精医疗 share price and the full management transaction log of the company, a listed equity based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 奥精医疗 has published 12 insider filings. Market capitalisation: €1.8bn. The latest transaction was reported on 31 December 2025 (Sale). Among the most active insiders: 宋天喜. All data is openly available.
12
Insider Decl.
n/a
Thresholds
€140,188
1 ops.
Buy Volume
€382,608
11 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,813 of 29,063 companies
42.5
score / 100
Value27
Quality58
FCF yld0.6%
Earn yld0.8%
EV/EBITDA50.6x
ROE0.7%
Gross mgn69%
Net mgn6.2%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 December 2025
Declarations12 total
12 of 12 declarations
关于 奥精医疗
奥精医疗是一家在医疗保健和制药领域运营的公司，在XSHG市场上市。它专注于创新医疗产品的开发和商业化。